Back Stocks profile

Stock analysis tool for investors

Procter & Gamble Health Ltd.

NSE: PGHL | BSE:500126

₹5233.65 -17.95 (-0.34%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

5216.40

Today’s High

5292.00

52W low

4636.60

52W High

5642.80

Open Price

5262.00

Prev. Close

4935.5500

Volume

4813.00

Value

25189557.45

Fundamentals

Market Cap

8687.50

Price to Earnings

40.60

Price to Book Value

11.60

Dividend Yield

4.80

PE to Growth

-3.60

Op Revenue TTM

1168.56

Net Profit TTM

214.02

Cash From Operating Activity

236.00

Return on Equity %

30.55

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 Jul, 2024

52.8

Week

51.3

Month

53.4

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

5247.32

PIVOT

First Resistance

5278.28

Second Resistance

5322.92

Third Resistance

5353.88

First Support

5202.68

Second Support

5171.72

Third Support

5127.08

Relative Strength Index

59.42

Money Flow Index

70.78

MACD

63.94

MACD Signal

63.83

Average True Range

121.66

Average Directional Index

25.53

Rate of Change (21)

4.54

Rate of Change (125)

0

Commodity Channel Index

113.2

Williams %R

-36.8

BETA

1 Month

0.23

3 Month

0.18

1 Year

0.19

3 Year

0.19

PRICE CHANGE ANALYSIS

1.42%

1 Week

Low

High

5108

5370

4.54%

1 Month

Low

High

4965.15

5370

10.53%

3 Months

Low

High

4639.25

5370

-0.79%

6 Months

Low

High

4636.55

5642.85

0.52%

1 Year

Low

High

4636.55

5642.85

Bigul
18 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

Dear Sir, Please find enclosed certificate as issued by Company''s PCS confirming compliance as required under Regulation 40(9) of the SEBI (LODR) Regulations. Request you to kindly take note of the same.
Bigul
18 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have issued duplicate share certificate to our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
17 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have received intimation from our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter. Kindly take the same on record.
Bigul
12 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, We have been informed by our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
08 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir, Please find attached compliance certificate under Regulation 74(5) of the SEBI (DP) Participants Rules, for the quarter ended June 30, 2024. Kindly take the same into record.
Bigul
08 Jul 2024

Procter & Gamble Health Ltd - 500126 - Compliance Certificate For The Year Ended June 30, 2024

Dear Sir, Please find attached confirmation certificate signed by the Company and RTA for compliance done during the Financial year ended June 30, 2024.
Bigul
27 Jun 2024

Procter & Gamble Health Ltd - 500126 - Closure of Trading Window

We would like to inform you that the Trading Window of the Company shall remain closed from July 1, 2024 until 48 hours from the publication of the audited financial results for the financial year ended June 30, 2024, as further detailed in enclosed letter.
Bigul
27 Jun 2024

Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 21, 2024

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 21, 2024, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2024 and to consider recommendation of dividend (if any).
Bigul
27 Jun 2024

Procter & Gamble Health Ltd - 500126 - Closure of Trading Window

Dear Sir, Please be informed that we have issued share certificate to our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.
Bigul
12 Jun 2024

Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

There has been a typographical error in the share certificate details mentioned in the earlier announcement of even date, in this regard find enclosed revised details with respect to loss of share certificates of shareholders of the Company as intimated by the RTA, Kfin technologies Limited.
See all News

FAQs

The latest market price of Procter & Gamble Health Ltd. on NSE was Rs. 5233.65 as of today.

The opening share price of Procter & Gamble Health Ltd. was Rs. 5262.00 as of today.

The 52-week high share price of Procter & Gamble Health Ltd. was Rs. 5642.80.

The 52 week low share price of Procter & Gamble Health Ltd. was Rs. 4636.60.

Please find Corporate actions section for more details.

The PE ratio of Procter & Gamble Health Ltd. is -3.60. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Procter & Gamble Health Ltd. was on 2024-02-14 for Rs. 150 per share. According to today’s share price, the dividend yield of Procter & Gamble Health Ltd. stands at 4.80. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Procter & Gamble Health Ltd..

Close

Let's Open Free Demat Account